
XOMA Corp
Prices are adjusted according to historical splits.

Vitals
- Today's Low:
- $21.0592
- Today's High:
- $23.1367
- Open Price:
- $22.17
- 52W Low:
- $15.68
- 52W High:
- $32.085
- Prev. Close:
- $22.23
- Volume:
- 27449
Company Statistics
- Market Cap.:
- $243.20 million
- Book Value:
- 10.823
- Revenue TTM:
- $6.03 million
- Operating Margin TTM:
- -288.93%
- Gross Profit TTM:
- $5.87 million
- Profit Margin:
- -283.79%
- Return on Assets TTM:
- -7.09%
- Return on Equity TTM:
- -12.87%
Company Profile
XOMA Corp had its IPO on 1989-04-05 under the ticker symbol XOMA.
The company operates in the Healthcare sector and Biotechnology industry. XOMA Corp has a staff strength of 12 employees.
Stock update
Shares of XOMA Corp opened at $22.17 at the start of the last trading session i.e. 2023-03-30.
The stocks traded within a range of $21.06 - $23.14, and closed at $21.85.
This is a -1.71% slip from the previous day's closing price.
A total volume of 27,449 shares were traded at the close of the day’s session.
In the last one week, shares of XOMA Corp have increased by +12.4%.
XOMA Corp's Key Ratios
XOMA Corp has a market cap of $243.20 million, indicating a price to book ratio of 1.656 and a price to sales ratio of 5.3427.
In the last 12-months XOMA Corp’s revenue was $6.03 million with a gross profit of $5.87 million and an EBITDA of $-17310000. The EBITDA ratio measures XOMA Corp's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, XOMA Corp’s operating margin was -288.93% while its return on assets stood at -7.09% with a return of equity of -12.87%.
In Q4, XOMA Corp’s quarterly earnings growth was a positive 37% while revenue growth was a negative 95.9%.
XOMA Corp’s PE and PEG Ratio
- Forward PE
- 30.4878
- Trailing PE
- 0
- PEG
- -0.42
Its diluted EPS in the last 12-months stands at $-2.05 per share while it has a forward price to earnings multiple of 30.4878 and a PEG multiple of -0.42. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into XOMA Corp’s profitability.
XOMA Corp stock is trading at a EV to sales ratio of 3.3873 and a EV to EBITDA ratio of 7.2888. Its price to sales ratio in the trailing 12-months stood at 5.3427.
XOMA Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $140.38 million
- Total Liabilities
- $6.82 million
- Operating Cash Flow
- $-15247000.00
- Capital Expenditure
- $15.25 million
- Dividend Payout Ratio
- 0%
XOMA Corp ended 2023 with $140.38 million in total assets and $0 in total liabilities. Its intangible assets were valued at $140.38 million while shareholder equity stood at $124.01 million.
XOMA Corp ended 2023 with $0 in deferred long-term liabilities, $6.82 million in other current liabilities, 86000.00 in common stock, $-1182392000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $57.83 million and cash and short-term investments were $57.83 million. The company’s total short-term debt was $34,000 while long-term debt stood at $0.
XOMA Corp’s total current assets stands at $61.25 million while long-term investments were $0 and short-term investments were $335000.00. Its net receivables were $1000.00 compared to accounts payable of $524000.00 and inventory worth $0.
In 2023, XOMA Corp's operating cash flow was $-15247000.00 while its capital expenditure stood at $15.25 million.
Comparatively, XOMA Corp paid $0 in dividends in 2023.
Other key metrics
- Current Trading Price
- $21.85
- 52-Week High
- $32.085
- 52-Week Low
- $15.68
- Analyst Target Price
- $62.5
XOMA Corp stock is currently trading at $21.85 per share. It touched a 52-week high of $32.085 and a 52-week low of $32.085. Analysts tracking the stock have a 12-month average target price of $62.5.
Its 50-day moving average was $21.11 and 200-day moving average was $19.89 The short ratio stood at 19.41 indicating a short percent outstanding of 0%.
Around 59.7% of the company’s stock are held by insiders while 6202% are held by institutions.
Frequently Asked Questions About XOMA Corp
Similar Industry Stocks (Biotechnology)
Most Active
Top Gainers
Top Losers
About
XOMA Corporation operates as a biotech royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with various assets. The company was incorporated in 1981 and is headquartered in Emeryville, California.